Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis
Ming Li, Feng Gao, Qing Zhao, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
Shan Wang, Jialei Fu, Huifeng Hao, et al.
Pharmacological Research (2021) Vol. 170, pp. 105728-105728
Closed Access | Times Cited: 140
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 53
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine
Wenfeng Zhang, Cun Liu, Jie Li, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 01, pp. 209-239
Closed Access | Times Cited: 53
Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction
Ruoning Chai, Zelin Ye, Wenjing Xue, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 34
Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer
Na Luo, Kejing Zhang, Xin Li, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 12
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
Xuan Ni, Chengpiao Lu, Guo-qiang Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1533-1555
Closed Access | Times Cited: 11
The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
Jingli Xu, Yuan Li, Yancheng Tang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Ubiquitination regulation of aerobic glycolysis in cancer
Yao Xie, Mu Wang, Min Xia, et al.
Life Sciences (2022) Vol. 292, pp. 120322-120322
Closed Access | Times Cited: 31
A new strategy for osteoarthritis therapy: Inhibition of glycolysis
Chunmei Tan, Lanqing Li, Juanjuan Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Weijia Wang, Wenjun Liu, Qiuli Chen, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 84-97
Closed Access | Times Cited: 30
NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation
Guangping Zhang, Xin Zhao, Weixian Liu
Cancer Biology & Therapy (2022) Vol. 23, Iss. 1, pp. 243-253
Open Access | Times Cited: 28
Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis
Tianxiang Wang, Kun‐Long Duan, Zixuan Huang, et al.
Life Science Alliance (2022) Vol. 6, Iss. 1, pp. e202201667-e202201667
Open Access | Times Cited: 26
Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway
Guangzhao Huang, Su Chen, Jumpei Washio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1992-1992
Open Access | Times Cited: 16
Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
Yaoquan Cao, Haibo Tang, Guohui Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Dioscin inhibits non-small cell lung cancer cells and activates apoptosis by downregulation of Survivin
Ruirui Wang, M Kellis, Gan Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 5, pp. 1366-1377
Open Access | Times Cited: 6
Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression
Jing Bai, Qiufeng Qin, Shuying Li, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118281-118281
Closed Access | Times Cited: 5
Tanshinone IIA inhibits cell growth by suppressing SIX1‑induced aerobic glycolysis in non‑small cell lung cancer cells
Hailiang Qi, Zhengyi Chen, Yuhuan Qin, et al.
Oncology Letters (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 21
N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression
Xu Ke, Xiaojuan Dai, Jiankun Wu, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3375-3384
Closed Access | Times Cited: 20
Bergenin Inhibits Tumor Growth and Overcomes Radioresistance by Targeting Aerobic Glycolysis
M Kellis, Li Xie, Zhou Li, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 07, pp. 1905-1925
Closed Access | Times Cited: 13
Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis
Li Xie, Jinzhuang Liao, Wenbin Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
Mi-Ju Park, Jung Ho Han, Shibo Wei, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 807-807
Open Access | Times Cited: 4
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
Wenyue Shen, Quanwei Zhou, Chenxi Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 19
Natural products targeting glycolysis in cancer
Yuanyuan Zhao, Louisa S. Chard, Zhenguo Cheng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
From natural herbal wisdom to nano innovation: Revolutionizing tumor treatment through metabolic reprogramming
Zhengguang Zhang, Haitao Wu, Min Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189263-189263
Closed Access
Page 1 - Next Page

Scroll to top